• Latest Posts

Ascletis phase I COVID trial progressing

Ascletis announces positive COVID-19 trial results

FDA gives IND approval for Ascletis Covid drug

Ascletis announces IND approval for treatment of advanced solid tumors

Ascletis is first Chinese biotech company to get IND approvals for oral RdRp inhibitor


Ascletis announces FDA clearance of oral drug to conduct study in mild to moderate COVID-19 patients